4
Changes in Ownership
Enliven Therapeutics, Inc. Filed Acc 0001209191-22-009391
Director bought 31,826 shares at an average $1.23 ($39,246)
From the SEC's structured data for this filing
Trades in this filing
MOTT DAVID M · Director
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-02-10 | Purchase : show line 1 in the form | +8,753 | $1.29 | $11,291 | 8,753 | D |
| 2022-02-11 | Purchase : show line 2 in the form | +14,573 | $1.23 | $17,925 | 23,326 | D |
| 2022-02-14 | Purchase : show line 3 in the form | +8,500 | $1.18 | $10,030 | 31,826 | D |
| Open-market purchases · 31,826 sh · avg $1.23 · $39,246 | ||||||
Loading xslF345X03/doc4.xml…